Full-Time

Clinical Pharmacist

Posted on 9/16/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$112.4k - $187.4k/yr

Elk Grove Village, IL, USA

In Person

Willing to travel up to 5% of the time for business purposes (within state).

US Citizenship Required

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • Graduate of an accredited School of Pharmacy.
  • Current, active Pharmacy license as granted by the State Board of Pharmacy.
  • One of the following: (a) At least one 1 year of experience in sterile IV admixture procedures (b) knowledge of non-sterile compounding, immunizations and medication therapy management (MTM) (c) completion of an ASHP accredited Pharmacy Residency Program, (d) completion of an Advanced Pharmacy Practice Experience associated with an accredited school of pharmacy or (e) equivalent experience as approved by the Vice President (VP) of Pharmacy and/or Sr. Vice President (SVP) of Clinical Services.
Responsibilities
  • Determines the suitability of individual patients for home care. Collects and organizes all patient-specific information needed to determine the suitability of patients for home care. Assesses patients' suitability for home care in accordance with Option Care policies. Medical condition and prescribed medication therapy suitable for home care services and prognosis with clearly defined outcome goals.
  • Designs, recommends, monitors and evaluates patient-specific pharmacy care plans for the pharmacotherapy of home care patients. When appropriate, makes suitable recommendations for modifications in the prescribed medication therapy or monitoring parameters for a home care patient. Collects and organizes patient-specific information needed to prevent, detect, and resolve medication-related problems and to make appropriate medication therapy recommendations. Appropriate monitoring parameters are identified for each patient. Completes nutritional assessment of patients and makes appropriate recommendation.
  • Modifies the pharmacy care plans for home care patients based on evaluation of monitoring data and other pertinent patient-specific information. Competent in use of pharmacokinetic principles and formulas. Competent in assessing patient laboratory values.
  • Provides medication-use education to Option Care staff, other professionals, home care patients and/or their caregivers. Uses effective patient education techniques to provide counseling to home care patients and/or their caregivers.
  • Ensures continuity of pharmaceutical care to and from the home and other patient-care settings. Uses a systematic procedure to communicate pertinent patient information to and from the home and other patient-care settings. Prepares and dispenses medications using appropriate techniques and following Option Care policies and procedures. Accurately calibrates equipment. Prepares medications so they are appropriately concentrated, without incompatibilities, stable, and appropriately stored. Adheres to appropriate safety and quality assurance practices. Prepares labels that conform to the organization's policies and procedures. Medication contains all necessary and/or appropriate ancillary labels. Inspects the final medication before dispensing. Assures presence of authorization to dispense. Complies with state/federal laws and USP standards, including Drug Enforcement Administration (DEA) controlled substance regulations set forth by the state and DEA. Complies with policies regarding the perpetual inventory systems for schedule II narcotics, controlled substances and other medications subject to diversion.
  • Manages the use, maintenance, and troubleshooting of medication administration equipment and medication-related equipment used in the management of home care patients. Accurately programs, maintains and gives advice to others on the use and maintenance of all medication administration and medication-related equipment used by Option Care. Participates in the process for assessing, managing, and reporting medication-related incidents and equipment error and/or failures. Accurately completes QAR documents according to the Option Care policy. Monitors and reports discrepancies in perpetual inventory systems for schedule II narcotics and other medications subject to diversion.
  • Provides concise, applicable, and timely response to requests for drug information from health care providers and home care patients. Formulates responses to drug information requests based on analysis of the literature. Attends educational seminars or participates in other CEU opportunities in order to promote professional competency and complies with state mandated CEU requirements.
  • Manages the use of investigational drug products according to established regulations and Option Care policies and procedures. Utilizes pharmacy support personnel effectively. Prioritizes the workload and organizes the workflow, taking into account available resources. Needed work is accomplished in the time available. Ensures the accuracy of the work of pharmacy support personnel.
  • In all activities, complies with accreditation, legal, regulatory, and safety requirements.
  • Maintains confidentiality of patient and proprietary information. Observes legal and ethical guidelines for safeguarding the confidentiality of patient and proprietary Option Care information.
Desired Qualifications
  • Completion of an ASHP accredited Pharmacy Residency Program or an Advanced Pharmacy Practice Experience associated with an accredited school of pharmacy
  • Experience in home care, hospital or other clean room setting

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE